Page last updated: 2024-10-25

deferoxamine and Infertility, Female

deferoxamine has been researched along with Infertility, Female in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Infertility, Female: Diminished or absent ability of a female to achieve conception.

Research Excerpts

ExcerptRelevanceReference
"Pregnancy was well tolerated by the heart in all women and no endocrinological disorders were observed."1.30Fertility in thalassemia: the Greek experience. ( Karagiorga-Lagana, M, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ni, Z1
Li, Y1
Song, D1
Ding, J1
Mei, S1
Sun, S1
Cheng, W1
Yu, J1
Zhou, L1
Kuang, Y1
Li, M1
Cai, Z1
Yu, C1
Karagiorga-Lagana, M1

Other Studies

2 other studies available for deferoxamine and Infertility, Female

ArticleYear
Iron-overloaded follicular fluid increases the risk of endometriosis-related infertility by triggering granulosa cell ferroptosis and oocyte dysmaturity.
    Cell death & disease, 2022, 07-04, Volume: 13, Issue:7

    Topics: Animals; Deferoxamine; Endometriosis; Female; Ferroptosis; Follicular Fluid; Granulosa Cells; Humans

2022
Fertility in thalassemia: the Greek experience.
    Journal of pediatric endocrinology & metabolism : JPEM, 1998, Volume: 11 Suppl 3

    Topics: Adult; beta-Thalassemia; Cesarean Section; Chelating Agents; Deferoxamine; Endocrine Glands; Female;

1998